Results 51 to 60 of about 52,753 (266)

Efavirenz use during pregnancy and for women of child-bearing potential

open access: yesAIDS Research and Therapy, 2006
Background Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic ...
Gray Glenda E   +7 more
doaj   +1 more source

A simple high-performance liquid chromatographic assay for concurrent quantification of lumefantrine and efavirenz in human plasma from malaria–HIV co-infected individuals

open access: yesFuture Journal of Pharmaceutical Sciences, 2023
Background As per current treatment guidelines, artemether-lumefantrine and efavirenz-based antiretroviral therapy are recommended drugs for falciparum malaria and human immunodeficiency virus (HIV) infections, respectively.
Adebanjo J. Adegbola   +3 more
doaj   +1 more source

Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW). [PDF]

open access: yes, 2016
We conducted a longitudinal and cross-sectional analysis of depressive symptomology in iPrEx, a randomized, placebo-controlled trial of daily, oral FTC/TDF HIV pre-exposure prophylaxis (PrEP) in men and transgender women who have sex with men. Depression-
Amico, K Rivet   +13 more
core   +1 more source

Histopathological effect of co-administration of efavirenz and vitamin E on the liver, and biochemical parameters in wistar rats

open access: yesAsian Journal of Medical Sciences, 2016
Background: Efavirenz is a drug used in combination as highly active antiretroviral therapy (HAART) used for the treatment of human immunodeficiency virus (HIV).
Aniekan I Peter
doaj   +1 more source

Chronic toxicity and environmental risk assessment of antivirals in Ceriodaphnia dubia and Raphidocelis subcapitata

open access: yesWater Science and Technology, 2021
Antiviral drugs are a class of medications used for treating viral infections. Due to their widespread use, especially in cases of pandemics and limited human metabolism, antivirals have been detected in multiple environmental matrices.
L. C. Almeida   +4 more
doaj   +1 more source

Preferred antiretroviral drugs for the next decade of scale up [PDF]

open access: yes, 2012
Global commitments aim to provide antiretroviral therapy (ART) to 15 million people living with HIV by 2015, and recent studies have demonstrated the potential for widespread ART to prevent HIV transmission.
Andrieux-Meyer, Isabelle   +10 more
core   +4 more sources

Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent model [PDF]

open access: goldTranslational Psychiatry, 2019
Efavirenz is recommended as a preferred first-line drug for women of childbearing potential living with human immunodeficiency virus. Efavirenz is known for its central nervous system side effects, which are partly mediated by serotonergic actions.
Lisa Van de Wijer   +11 more
openalex   +2 more sources

Depression is associated with efavirenz-containing treatments in newly antiretroviral therapy initiated HIV patients in Ecuador

open access: yesAIDS Research and Therapy, 2020
Background It is well known that people living with HIV (PLWH) is in higher risk for the development of depression and it has also been suggested that the use of efavirenz into the antiretroviral regimens increases even that risk.
Alejandro Checa   +5 more
semanticscholar   +1 more source

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America

open access: yesBMC Infectious Diseases, 2018
Background Efavirenz-based antiretroviral therapy (ART) regimens are preferred for treatment of adult HIV-positive patients co-infected with tuberculosis (HIV/TB).
Yanink Caro-Vega   +20 more
doaj   +1 more source

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. [PDF]

open access: yes, 2007
BACKGROUND: HAART efficacy was evaluated in a real-life setting in Phnom Penh (Médecins Sans Frontières programme) among severely immuno-compromised patients.
Akileswaran   +30 more
core   +3 more sources

Home - About - Disclaimer - Privacy